The event brings 600 people together including 200 investors, representatives from the multinational strategics and C-suites from emerging companies with the aim of progressing deals.
Through an MOU made earlier this year, MTPConnect and Biocom California have committed to working closely together to support the growth of life sciences companies, and this conference has been identified as an opportunity for Australian companies to consider.
Are you looking for capital?
Attending international conferences can require a large investment, but for those looking for capital, this one should be on your radar.
The cost to participate is a worthwhile investment – USD$1,326 for companies with 10 people or less (also Academic institutions) or $3,372 for companies with 11 < 50 staff.
More details can be found on https://www.biocom.org/conferences/global-partnering-conference/
and the agenda is packed with a range of interesting sessions covering venture capital trends, big pharma’s approach to partnering and growth, AI and drug discovery, the life science IPO journey and more.
With 15 years in the making, 50 company presentations, 1,000+ One-on-One meetings, 20+ participating countries and a capped attendance of 600 participants, the conference delivers great value.
Investors in attendance
The list of investors attending Biocom California’s premier conference is impressive:
For more information, contact Jarrod Belcher via email: jarrod.belcher@mtpconnect.org.au